| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/07/1998 | CA2018229C Carboplatin composition |
| 04/02/1998 | WO1998013385A2 Non-naturally occurring lipoprotein particle |
| 04/02/1998 | WO1998013359A1 Ultramicroemulsion of spontaneously dispersible concentrates of esters of baccatin-iii compounds with antitumor and antiviral effect |
| 04/02/1998 | WO1998013136A1 Method for preparing microcapsules of active substances coated with a polymer and novel microcapsules in particular resulting from the method |
| 04/02/1998 | WO1998013069A2 Fluorinated copolymeric pharmaceutical adjuncts |
| 04/02/1998 | WO1998013068A1 Medicinal prophylactic 'trisan' |
| 04/02/1998 | WO1998013055A1 Antioxidizing composition for scavenging free radicals, pharmaceutical composition comprising the same, and process for preparing the same |
| 04/02/1998 | WO1998013053A1 Mistletoe (viscum) extracts |
| 04/02/1998 | WO1998013052A1 Anti-allergic and anti-inflammatory product, method for producing the same, cosmetic product and hygienic product |
| 04/02/1998 | WO1998013042A1 Antimycotic gel with high active substance release |
| 04/02/1998 | WO1998013035A1 Percutaneous preparations |
| 04/02/1998 | WO1998013032A1 Compositions of therapeutic agents suitable for oral administration |
| 04/02/1998 | WO1998013031A2 Medicinal aerosol formulations comprising budesonide |
| 04/02/1998 | WO1998013030A1 Biodegradable ionic matrix of variable internal polarity with grafted polymer |
| 04/02/1998 | WO1998013029A1 Oral delayed immediate release formulation and method of preparation therefor |
| 04/02/1998 | WO1998013028A1 Oral preparation containing at least one active pharmaceutical substance in a matrix capable of swelling in an aqueous medium |
| 04/02/1998 | WO1998013027A1 Coated particle formulation |
| 04/02/1998 | WO1998013026A1 Cationic amphiphile compositions for intracellular delivery of therapeutic molecules |
| 04/02/1998 | WO1998013025A1 Structures with double lipidic membranes or based on peptides |
| 04/02/1998 | WO1998013024A2 Hyaluronic drug delivery system |
| 04/02/1998 | WO1998013023A1 A product, a method for its production, and its use |
| 04/02/1998 | WO1998013021A1 Preparation protecting skin from mechanical irritation |
| 04/02/1998 | WO1998013013A1 Improved products and methods for the remineralization and prevention of demineralization of teeth |
| 04/02/1998 | WO1998013007A2 Methods and compositions for lipidization of hydrophilic molecules |
| 04/02/1998 | WO1998013001A1 Intranasal formulations for promoting sleep and method of using the same |
| 04/02/1998 | WO1998012987A1 Microparticle formulation and method for inhibiting smooth muscle cell migration and proliferation |
| 04/02/1998 | WO1998012936A1 Tablets containing a sweetening mixture |
| 04/02/1998 | WO1998012933A1 Chewing gum with sweetening agent |
| 04/02/1998 | DE19640364A1 Topische Mittel zur Prophylaxe oder Behandlung bakterieller Hautinfektionen Topical agents for the prophylaxis or treatment of bacterial skin infections |
| 04/02/1998 | DE19639816A1 Antimykotische Mittel mit hoher Wirkstofffreisetzung Antifungal agent with high drug release |
| 04/02/1998 | DE19639375A1 Mistel-Trockenextrakte Mistletoe dried extracts |
| 04/02/1998 | DE19639343A1 Komprimate, enthaltend ein Süßungsmittelgemisch Compacts containing a sweetener |
| 04/02/1998 | CA2268958A1 A product, a method for its production, and its use |
| 04/02/1998 | CA2268945A1 Cationic amphiphile compositions for intracellular delivery of therapeutic molecules |
| 04/02/1998 | CA2267179A1 Methods and compositions for lipidization of hydrophilic molecules |
| 04/02/1998 | CA2266898A1 Intranasal formulations for promoting sleep and method of using the same |
| 04/02/1998 | CA2266642A1 Biodegradable ionic matrix of variable internal polarity with grafted polymer |
| 04/02/1998 | CA2266448A1 Coated particle formulation |
| 04/02/1998 | CA2266431A1 Medicinal aerosol formulations comprising budesonide |
| 04/01/1998 | EP0832647A1 Topical oil-in-water fluid emulsions having a high content of glycol |
| 04/01/1998 | EP0832569A2 Preparing powdery carotenoide compounds dispersible in cold water and their use |
| 04/01/1998 | EP0832446A1 Therapeutic microdevices and methods of making and using same |
| 04/01/1998 | EP0832272A1 Cationic lipid:dna complexes for gene targeting |
| 04/01/1998 | EP0832271A2 Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer |
| 04/01/1998 | EP0832270A1 Cationic lipid:dna complexes for gene targeting |
| 04/01/1998 | EP0832236A1 Methods for enhancement of protective immune responses |
| 04/01/1998 | EP0832109A1 Fibroblast growth factor homologous factor-2 and methods of use |
| 04/01/1998 | EP0831963A1 Micromachined porous membranes with bulksupport |
| 04/01/1998 | EP0831942A1 Transdermal drug delivery device for treating erectile dysfunction |
| 04/01/1998 | EP0831933A1 Site specific binding system, imaging compositions and methods |
| 04/01/1998 | EP0831927A1 Stabilized compositions of fluorinated amphiphiles as contrast agents for ultrasound |
| 04/01/1998 | EP0831923A1 Separation of active complexes |
| 04/01/1998 | EP0831912A1 Improved formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
| 04/01/1998 | EP0831886A1 Thrombopoietin compositions |
| 04/01/1998 | EP0831870A1 Use of essential oils to increase bioavailability of oral pharmaceutical compounds |
| 04/01/1998 | EP0831867A1 Collagen-based delivery matrix |
| 04/01/1998 | EP0831858A1 Intrauterine chemical necrosing method and composition |
| 04/01/1998 | EP0831857A2 Phosphate-binding polymers for oral administration |
| 04/01/1998 | EP0831855A1 Nucleotide analogues for topical treatment of proliferative disease of the skin |
| 04/01/1998 | EP0831850A1 Use of locally applied dna fragments |
| 04/01/1998 | EP0831847A2 Use of di-beta-d-glucopyranosylamine compounds for controlling inflammatory reactions, and method of synthesis |
| 04/01/1998 | EP0831840A1 Use of non-steroidal anti-inflammatory agents to improve the physiological compatibility of particular pharmaceutical preparations |
| 04/01/1998 | EP0831836A1 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
| 04/01/1998 | EP0831827A1 Novel formulations for transdermal delivery of pergolide |
| 04/01/1998 | EP0831826A1 Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride |
| 04/01/1998 | EP0831825A1 Pharmaceutical formulations of highly lipophilic camptothecin derivatives |
| 04/01/1998 | EP0831820A1 Oral pharmaceutical composition of piperidinoalkanol compounds in solution form |
| 04/01/1998 | EP0831810A1 Transdermal formulation comprising ropinirole |
| 04/01/1998 | EP0831808A1 Osteogenetic promoting pharmaceutical composition |
| 04/01/1998 | EP0831803A1 Sorbic-acid-containing hydrogels |
| 04/01/1998 | EP0831802A1 Treatment of a trabecular meshwork whose cells are subject ot inhibition of cell division with non-steroidal anti-inflammatory drugs |
| 04/01/1998 | EP0831801A1 Non-steroidal anti-inflammatory drugs for the cyto-protection of the trabecular meshwork |
| 04/01/1998 | EP0831796A1 Method for reducing or preventing post-surgical adhesion formation using 5-lipoxygenase inhibitors |
| 04/01/1998 | EP0831794A1 Acyclovir derivatives for topical use |
| 04/01/1998 | EP0831793A1 Protein particles for therapeutic and diagnostic use |
| 04/01/1998 | EP0831792A2 Apparatus and method for delivering a biologically active compound into a biological environment |
| 04/01/1998 | EP0831791A1 Delivery of drugs to the lower gi tract |
| 04/01/1998 | EP0831790A2 Methods for stably incorporating substances within dry, foamed glass matrices and compositions obtained thereby |
| 04/01/1998 | EP0831789A1 Stable pharmaceutical compositions containing tiludronate hydrates and process for producing the pharmaceutical compositions |
| 04/01/1998 | EP0831788A1 Spray drying method and apparatus |
| 04/01/1998 | EP0831787A2 Composition for sustained release of human growth hormone |
| 04/01/1998 | EP0831786A2 Device for releasing aggregation-stabilized, biologically active agent |
| 04/01/1998 | EP0831785A1 Method for the manufacture of minimal volume capsules containing biological material |
| 04/01/1998 | EP0831784A1 Fragrances and flavorants |
| 04/01/1998 | EP0831783A1 Oral veterinary fluoroquinolone antibacterial composition for extended duration of therapy and method of treating |
| 04/01/1998 | EP0831782A1 Methods and system for processing dispersible fine powders |
| 04/01/1998 | EP0831781A1 Submicron liposome suspensions obtained from preliposome lyophilizates |
| 04/01/1998 | EP0831780A1 Improved liposomal formulation |
| 04/01/1998 | EP0831779A1 Process for making liposome preparation |
| 04/01/1998 | EP0831778A1 Intracellular delivery of macromolecules |
| 04/01/1998 | EP0831777A1 Dinucleotides useful for the treatment of lung disease |
| 04/01/1998 | EP0831776A2 Liquid fluorocarbon emulsion as a vascular nitric oxide reservoir |
| 04/01/1998 | EP0831775A1 Sustained release ophthalmic emulsions |
| 04/01/1998 | EP0831774A1 Oral dosage and method for treating painful conditions of the oral cavity |
| 04/01/1998 | EP0831773A1 Peptide/protein suspended formulations |
| 04/01/1998 | EP0831771A2 Oral delivery of gene constructs |
| 04/01/1998 | EP0831770A1 Continuous fluorochemical microdispersions for the delivery of pharmaceutical agents |
| 04/01/1998 | EP0831752A1 A device for delivering a preselected molecule into the system circulation |
| 04/01/1998 | EP0831703A1 Method of solubilizing and encapsulating itraconazole |
| 04/01/1998 | EP0800364A4 Transdermal administration of apomorphine |